Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
The Valens Company Inc.

The Valens Company Inc. (VLNS) Stock Overview

Explore The Valens Company Inc.’s financial performance, market position, analyst ratings, and future outlook.

VLNS●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.76
$0.00(0.00%)
U.S. Market is Open · 14:50

The Valens Company Inc. (VLNS)

Meyka AI Score

Z

Key Financials

Market Cap61.5M
P/E RatioN/A
EPS (TTM)$-0.74
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

VLNS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of The Valens Company Inc. (NASDAQ: VLNS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, The Valens Company Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of VLNS on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.

Key metrics behind The Valens Company Inc.'s NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 61.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of VLNS on the NASDAQ.

Price Performance (NASDAQ: VLNS)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
-1.65%
3-Year Change
-1.65%
5-Year Change
-1.65%
All-Time (Max) Change
-1.65%

Contact Information

https://www.thevalenscompany.com
NaN
96 Spadina Avenue, Toronto, ON, M5V 2J6

Company Facts

4,450 Employees
IPO DateSep 28, 2009
CountryCA

Frequently Asked Questions